A randomised, double blind, placebo controlled study of dronabinol in opioid withdrawal

Trial Profile

A randomised, double blind, placebo controlled study of dronabinol in opioid withdrawal

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Aug 2016

At a glance

  • Drugs Dronabinol (Primary) ; Oxycodone
  • Indications Drug dependence; Opioid abuse; Substance withdrawal syndrome
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top